Wednesday, April 28, 2021 2:01:35 PM
https://collaboration.fda.gov/ODAC04282021?disclaimer-consent=true&proto=true
https://www.evaluate.com/vantage/articles/news/policy-and-regulation/three-days-reckoning-checkpoint-blockers
hyperopia Monday, 04/26/21 01:33:59 PM
Re: ae kusterer post# 372527 0
Post #
372573
of 372774
April 27-29, 2021 ODAC Meeting Webcast Information
The Center for Drug Evaluation and Research (CDER) plans to hold the April 27-29, 2021, meeting of the Oncologic Drugs Advisory Committee virtually via live webcast. Please note that the webcastwillnotdisplayuntilthemeeting beginsatapproximately1:00p.m.ESTonApril27, 2021 and 9:00 a.m. EST on April 28 and April 29, 2021. While CDER is working to ensure that the webcast is stable throughout the meeting, there may be instances where its transmission is interrupted; staff will work to re-establish the transmission as soon as possible. CDER plans to post archived webcasts after the meeting.
Webcasts of advisory committee meetings provided by CDER have limited capacity. Once capacity of the webcast is reached, no additional individuals will have access to the webcast unless others have exited the webcast. If an individual signs off from the webcast, CDER cannot guarantee that this person will be able to sign back on if capacity has been reached.
The meeting webcast can be accessed at the following web addresses:
April 27, 2021: https://collaboration.fda.gov/ODAC04272021
April 28, 2021: https://collaboration.fda.gov/ODAC04282021
April 29, 2021: https://collaboration.fda.gov/ODAC04292021
Note: At the access page, please sign in as a guest. No password is required.
General Information:
The webcast will be broadcast using Adobe Connect. You can check to determine if your computer has the correct plug-ins in order to view the webcast by accessing the following web site:?https://collaboration.fda.gov/common/help/en/support/meeting_test.htm
To access a quick overview summary of the Adobe Connect software visit: http://www.adobe.com/go/connectpro_overview
Please direct all technical inquiries to the appropriate support (listed below):
Virtual-WOCC-Support@fda.hhs.gov
For further information regarding webcasts and archived webcasts, and for contact information of staff available to assist with questions, please visit the “Human Drug Advisory Committees” page of the FDA website at: https://www.fda.gov/advisory-committees/committees-and-meeting- materials/human-drug-advisory-committees
https://www.fda.gov/media/147853/download
InvestorsHub NewsWire
Featured Umbria Token Fully Compatible with Polygon's Layer 2 Chain Apr 27, 2021 3:14 AM
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM